GH研究制药

最新新闻

• Wells Fargo Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $44
  \u5e02\u573a\u8d44\u8baf · 2026/8/31
• 评级变动
  A Quick Look at Today's Ratings for GH Research(GHRS.US), With a Forecast Between $32 to $39
  \u5e02\u573a\u8d44\u8baf · 2026/5/15
• 评级变动
  Needham Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $32
  \u5e02\u573a\u8d44\u8baf · 2026/3/6
• 评级变动
  Analysts Offer Insights on Healthcare Companies: GH Research (GHRS) and Sionna Therapeutics, Inc. (SION)
  TipRanks · 2026/3/7
• 评级变动
  RBC Capital Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40
  \u5e02\u573a\u8d44\u8baf · 2026/5/16
• 评级变动
  Cantor Fitzgerald Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $35
  \u5e02\u573a\u8d44\u8baf · 2026/5/16
• 评级变动
  Wells Fargo Initiates GH Research(GHRS.US) With Buy Rating, Announces Target Price $44
  \u5e02\u573a\u8d44\u8baf · 2026/7/27
• H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $65
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  Needham Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $39
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Cuts Target Price to $65
  \u5e02\u573a\u8d44\u8baf · 2026/5/19
• 评级变动
  Guggenheim Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $34
  \u5e02\u573a\u8d44\u8baf · 2026/3/10
• 评级变动
  Guggenheim Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $40
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  H.C. Wainwright Reaffirms Their Buy Rating on GH Research (GHRS)
  TipRanks · 2026/4/29
• 评级变动
  Stifel Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $32
  \u5e02\u573a\u8d44\u8baf · 2026/3/6
• CCORF Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39
  \u5e02\u573a\u8d44\u8baf · 2026/8/8
• 评级变动
  Analysts Are Bullish on Top Healthcare Stocks: GH Research (GHRS), MapLight Therapeutics, Inc. (MPLT)
  TipRanks · 2026/5/15
• 评级变动
  H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $70
  \u5e02\u573a\u8d44\u8baf · 2026/4/29
• Cantor Fitzgerald Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $40
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• TD Cowen Maintains GH Research(GHRS.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  Citizens JMP Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $42
  \u5e02\u573a\u8d44\u8baf · 2026/3/6

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。